1. Introduction {#sec0005}
===============

Plants and their secondary metabolites have been used as one of the important sources in the field of medicines or health related issues since ancient times. The role of medicinal plants in the health care had been already mentioned in the Indian holy books like "Vedas" \[[@bib0005]\]. Recent report of World Health Organization (WHO) has been estimated that approx 45,000 plants being practiced for the medicinal purposes across the globe \[[@bib0010]\]. Presently, around 65% of Indian population directly are dependent upon the traditional medicine for their need of primary health \[[@bib0015]\]. Secondary metabolites of these herbal plants is an alternative source broadly used in the treatment of chronic diseases \[[@bib0020]\]. Currently, traditional medicine is broadly used in the treatment of ulcer worldwide, and has been proven as one of the best strategies for the disease management of ulcer ([Fig.1](#fig0005){ref-type="fig"}).Fig. 1Overview of anti-ulcer metabolites from plant.Fig. 1

Ulcer is a discontinuity or break in a bodily membrane in the form of wound or sores that are slow healing or keep returning. It impedes the organ of which that membrane is a part from continuing its normal functions (<https://en.wikipedia.org/wiki/Ulcer>). It is of many forms which occur on both, inside and outside of the human body. Currently, different types of ulcer forms are recognized in medicine such as peptic ulcer, corneal ulcer, stomach ulcer, foot or leg ulcer *etc*.

Ulcer causing problems in digestive system and wounds appearing in the lining of digestive track in human beings are very common. The digestive track of human beings is very sensitive and the health of digestive track can be good or bad and depends on many factors. Pepsin exposed ulcers *i.e.*, peptic Ulcers are the most common type in the gastrointestinal tract area that result from an imbalance between stomach acid-pepsin and mucosal defence barriers and more than 4 million people affected worldwide annually \[[@bib0025],[@bib0030]\].

In medicine, the ulcer which occurs as mucosal lesions which penetrate the muscularis mucosae layer and form a cavity surrounded by acute and chronic inflammation is defined as peptic ulcer \[[@bib0035]\].

Peptic Ulcers can be divided into two common types according to location, *i.e*. gastric ulcer (in stomach) and duodenal ulcer (in duodenum). More specific classification includes1**Type I:** Ulcer along the lesser curve of stomach2**Type II:** Two ulcers present - one gastric, one duodenal3**Type III:** Prepyloric ulcer4**Type IV:** Proximal gastroesophageal ulcer5**Type V:** Anywhere

Peptic ulcer disease (PUD) is an illness that affects a considerable number of people worldwide. It is produced whenever there is imbalance between the gastro-duodenal mucosal defence mechanisms *i.e*. 'protective' factor and 'aggressive factor' of the luminal surface of the epithelial cells, combined with superimposed injury from environmental or immunologic agents. The aggressive factors inculde *Helicobacter pylori*, HCl, pepsins, nonsteroidal anti-nflammatory drugs (NSAIDs), bile acids, ischemia, hypoxia, smoking and alcohol \[[@bib0040]\].

2. Symptoms {#sec0010}
===========

Inspite of serious bleeding, big ulcer shows some common symptoms ([Fig. 2](#fig0010){ref-type="fig"}) while small ulcers rarely or mayn't cause any symptoms \[[@bib0045]\].Fig. 2Some common symptoms of ulcer.Fig. 2

3. Treatments {#sec0015}
=============

Earlier there were mainly two ways for the treatment of the peptic ulcer, the prophylactic and therapeutic types.

3.1. Prophylactic mechanism (gastroprotective or cytoprotective) {#sec0020}
----------------------------------------------------------------

In this type of treatment, defensive factors are fortified with strengthened prostaglandin synthesis and stimulated somatostatin synthesis in addition with other gastroprotective actions inhibition of gastrin secretion \[[@bib0050], [@bib0055], [@bib0060]\].

In addition, oxidative damage prevention of gastric mucosa (by blocking lipid peroxidation and significant decrease in superoxide dismutase along with increase in catalase activity) (\[[@bib0065],[@bib0070]\]), possible participation of the NO-synthase pathway \[[@bib0075]\] and anti-inflammatory activities are several others gastroprotective effects which helps in the treatment of the peptic ulcers.

3.2. Therapeutic mechanism {#sec0025}
--------------------------

Therapeutic agents cure the diseases *via.* antisecreatory or healing activities. Antisecreatory activity has the antagonism of histaminergic and cholinergic effects on gastric secretion or proton pump inhibition mechanism while healing activity works by making ulcer to heal by local mucosal enhancement.

3.3. Synthetic drugs {#sec0030}
--------------------

There is a plethora of different classes of pharmacological drugs that showed their efficacy in the treatment of peptic ulcer. Besides their novel cause, they could also destroy a person's life by causing a general deterioration of quality of life along with creating several other life hazards. Synthetic drugs of different classes applied in the treatment with their mechanism of action (MOA) and side effects are given in [Table 1](#tbl0005){ref-type="table"}.Table 1Synthetic drugs applied in the treatment, mode of action (MOA) and their side effects.Table 1Drug classMOAMedicine usedSide Effects**Anti-Muscarinie**•Blocks M1 muscarinic receptor•Dec. vagal stimulation•Inhibits gastric secretion•Dec. pepsin secretionPirenzepine•Dry mouth•Blurred Vision•Tachycardia•Photobia**H~2~-receptor blockers**•Inhibitor of H~2~ receptor (CYP450)Cimetidine, Famotidine, Ranitidine•Headaches,•Myalgia•Diarrhea,•Renal impairment,•Confusion**Prostaglandins**•Inhibits the acid secretion•Promotes mucus and bicarbonate secretionMisoprostol•Diarrhea•Abdominal pain•Vomiting and nausea•Headache**Antacids**•Neutralize the HCl•Reduces pepsin formationSodium bicarbonate, Calcium bicarbonate•Diarrhea•Constipation•Hypokalemia**Proton pump inhibitors**•Inhibits H^+^/K^+^ ATPase in parietal cellsOmeprazole, Esomeprazole, Pantoprazol•Risk of Pneumonia•Headaches•Diarrhea•Nausea•Weakness**Mucosal protective agents**•Forms a protective layer by binding with proteins found in base of the ulcer•Stimulates angiogenesis for healing•Inhibits pepsin activity•Antimicrobial activity against *H. pylori*Sucralfate, Bismuth Subsalicylate•Dry mouth•Skin rash•Headaches•Darkening of stools•Severe Constipation

4. Plant and their products with anti-ulcer activity {#sec0035}
====================================================

Natural products exhibit their antiulcerogenic activities *via.* prophylactic or therapeutic or by both ways. Extracts of *Saussurea lappa* C.B. Clarke \[[@bib0080]\], *Zizyphus oenoplia* (L.) Mill. \[[@bib0085]\], *Zingiber Officinale* Roscoe \[[@bib0075]\], *Butea frondosa* (Roxb.) \[[@bib0090]\], *Anacardium humile* St. Hil. \[[@bib0050]\], *Lasianthera Africana* P. Beauv. \[[@bib0095]\], *Gymnosporia rothiana* \[[@bib0100]\], *Coccinia grandis* Linn. \[[@bib0105]\] and *Zataria multiflora* Boiss. \[[@bib0110]\] showed cytoprotective mechanism to treat PUDs. Extracts possessing antioxidant mechanism in the gastroprotection are *Encholirium spectabile* Mart. \[[@bib0065]\], *Parkia platycephala* Benth. \[[@bib0115]\], *Glycyrrhiza glabra* L. \[[@bib0120]\] and C*arica papaya* L. \[[@bib0125]\].

Therapeutic agents are extracts of *Terminalia chebula* Retz. \[[@bib0130]\], *Mikania laevigat*a Schultz Bip. \[[@bib0135]\] and *Pausinystalia macroceras* (K. Schum.) Pierre ex Beille \[[@bib0140]\]. While plant extracts that perform through healing activity includes *Quassia amara* L. \[[@bib0145]\], *Matricaria chamomilla* L. \[[@bib0150]\] and D-002 (mixture of higher aliphatic primary alcohols isolated from beeswax) \[[@bib0155]\]. Another ways of wound healing mechanisms includes thick coating of the extract (like *Rhizophora mangle* L.) which is macroscopically adherent to the gastric mucosa, forming a physical barrier with similar properties as observed in topical wounds \[[@bib0160]\].

In addition, there are some plant extracts that exhibit both the prophylactic and therapeutic mechanisms like *Mentha arvensis* L. \[[@bib0165]\], *Polyalthia longifolia* (Sonn.) Thwaites (PL) \[[@bib0170]\], *Strychnos potatorum* Linn (Loganiaceae) \[[@bib0175]\], *Alhagi maurorum* Boiss. \[[@bib0180]\], *Indigofera truxillensis* Kunth \[[@bib0185]\], *Syngonanthus bisulcatus* (Koern) Ruhland \[[@bib0190]\], *Pausinystalia macroceras* (K. Schum.) *Pausinystalia yohimba* Pierre ex Beille \[[@bib0140]\] ([Table 2](#tbl0010){ref-type="table"}).Table 2Plants and their mode of action in ulcer treatment.Table 2PlantFamilyDose applied (mg kg^−1^)Mode of ActionReferences*Saussurealappa*Asteraceae200--400Cytoprotective effectSutar et al. \[[@bib0080]\]*Zizyphusoenoplia* (L.)Rhamnaceae300Increase in prostaglandin synthesisJadhav and Prasanna \[[@bib0085]\]*Zizyphus lotus* (L.)Lamiaceae50--200Cytoprotective agentsWahida et al. \[[@bib0195]\]*Quassiaamara* (L.)Simaroubaceae4.9--48.9Increase in gastric barrier mucus and non-protein sulfhydril groupsGarcia-Barrantes and Badilla \[[@bib0145]\]*Cocusnucifera* (L.)Arecaceae100--200NAAnosike and Obidoa \[[@bib0200]\]*Encholiriumspectabile*Bromeliaceae100Protection to gastric mucosa by activation of antioxidant systems and the involvement of prostaglandins and the NO synthase pathwayde Carvalho et al. \[[@bib0065]\]*Cissusquadrangularis* (L.)Vitaceae1000Protective effectsShanthi et al. \[[@bib0205]\]*Gynuraprocumbens (Merr.)*Asteraceae400Protective effectsMahmood et al. \[[@bib0210]\]*ZingiberOfficinale Roscoe*Zingiberaceae50--200Inhibition of ulcer index, prevented the oxidative damage of gastric mucosa by blocking lipid peroxidation, decrease in superoxide dismutase and increase in catalase activityArun et al. \[[@bib0075]\]*Butea frondosa (Roxb.)*Fabaceae250--500Gastroprotective activityLondonkar and Ranirukmini, \[[@bib0090]\]*Parkiaplatycephala*Leguminosae62.5--250Gastroprotective activity, antioxidant effect through increase in catalase activityFernandes et al. \[[@bib0115]\]*Anacardiumhumile*Anacardiaceae50Protect gastric mucosa due to increased PGE2 and mucous productionFerreira et al. \[[@bib0050]\]*Rhizophora mangle* L.Rhizophoraceae500Gastroprotective and antisecretory effects, in addition to increase in PGE2 levelsSánchez et al. \[[@bib0160]\]*Excoecariaagallocha* L.Euphorbiaceae62.5--125Decreases the acidity and increases the mucosal defense in the gastric areasThirunavukkarasu et al. \[[@bib0055]\]*Erythrinaindica* L.Fabaceae125--500NASachin and Archana \[[@bib0215]\]*Glycyrrhizaglabra* LFabaceae200Mucosal protective and antioxidant effects on the gastric mucosaLigha and Fawehinmi \[[@bib0120]\]*Virolasurinamensis (Rol. ex Rottb.) Kuntze*Myristicaceae500Inhibited mucosal injury, reduced the formation of gastric lesionsHiruma-Lima et al \[[@bib0220]\]*Combretumleprosum Mart. &Eiche*CombretaceaeInhibition of the gastric acid secretion and an increase of mucosal defensive factorsNunes et al. \[[@bib0225]\]*Gymnosporiarothiana (Walp.) Wight &Arn. ex M.A.Lawson*Celastraceae250--500Increasing gastric mucosal defense (prostaglandin and free radical scavenging)Jain and Surana \[[@bib0100]\]*Spathodea falcate*Bignoniaceae250--500Increasing gastric mucosal defense (prostaglandin and free radical scavenging)Jain and Surana \[[@bib0230]\]*Terminalia chebula Retz.*Combretaceae250--500Inhibition of the gastric lesions due to its antisecretoryRaju et al. \[[@bib0130]\]*Matricariachamomilla* L.Asteraceae400NAKarbalay-Doust and Noorafshan \[[@bib0150]\]*Morus alba* L. *(mulberry)*Moraaceae250--500Anti-inflammatory and antioxidant activityAbdulla et al. \[[@bib0235]\]*Camellia sinensis*Theaceae10Healing of gastric ulcer restoration of cellular antioxidant statusChatterjee et al. \[[@bib0240]\]*Centaurea bruguier*Asteraceae100 and 42Preventive activity against peptic ulcerKhanavi et al. \[[@bib0245]\]*Curcuma longa* L.Zingiberaceae20Antiulcerogenic, antioxidant and antiinflammatoryMahattanadul et al. \[[@bib0250]\]

Many researchers studied different plant species and their extracts to analyze their impact on ulcer treatments. Xiao et al. \[[@bib0255]\] during his study reported significant impact of *Abrus cantoniensis* ethanolic extract on the growth inhibition of *Helicobacter pylori*. The actual mechanism of action was not studied but they observed *Abrus cantoniensis* as a rich source of saponins, anthraquinones, alkaloids, flavonoids *etc*. The secondary metabolites present in the plants may act as anti-*Helicobacter pylori* substances since some metabolites analogues to the well-known anti-*Helicobacter pylori* compounds like cabreuvin, irisolidone, genistein and licoisoflavone \[[@bib0260], [@bib0265], [@bib0270]\] ([Table 3](#tbl0015){ref-type="table"}).Table 3List of some plants showing their part used as anti-ulcer activity.Table 3S.No.Botanical NameCommon nameFamilyPart Used1*Emblica officinalis*AamlaEuphorbiacaeFruit &Dried bark extract2*Azadirachta indica*NeemMeliaceaeextract, Leaves3*Bacopa monniera*BrahmiScrophulariaceaeFresh Juice4*Carica papaya*PapeetaCaricaceaeSeeds5*Ocimum sanctum*TulsiLabiataeAll plant parts6*Morinda citrifolia*MulberryRubiaceaeFruit7*Allophylus serratus*TippaniSapindaceaeLeaves8*Centella asiatica*Gotu KolaApiaceaeFresh Juice9*Desmodium gangeticum*ShaparniLeguminosaeRoot Extract10*Asparagus racemosus*SatavariLiliaceaeExtract of fresh root11*Zingiber officinalis*GingerZingiberaceaePowdered gingerrhizome12*Musa sapientum*Banana,MusaceaeFruit13*Aloe vera*GritkumariLiliaceaeLeaves14*Curcuma longa*HaldiZingiberaceaeRhizome15*Jatropha sativa*KalonjiEuphorbiaceaeLeaves16*Vitiveria ziziinoides*GraminaeBenacharRoot17*Bauhinia racemosa*Beedi leaf treeCaesalpiniaceaeFlower buds18*Capsicum annuum*ChilliSolanaceaeFruit19*Ageratum conyzoides*Goat weedAsteraceaeLeaves20*Trianthema pentandra*SalsabuniAizoaceaeWhole plant21*Quercus ilex*OakFagaceaeRoot bark22*Alstonia scholaris*SaptaparnApocynaceaeLeaves23*Punica granatum*AnaarLythraceaeFruit peel24*Ficus religiosa*PipalMoraceaeLeaves25*Momordica charantia*KarelaCucurbitaceaeSeeds26*Benincasa hipsida*PethakadduCucurbitaceaeFruits

*Saussurea lappa* is also a traditional medicinal plant having anti-*Helicobacter pylori* properties. This plant also has a rich source of sesquiterpenes, monoterpenes, triterpenes, aromatic compounds, sterols, alkaloid \[[@bib0275],[@bib0280]\]. Besides raw plant products or extracts, volatile oils of the plants also play a significant role in the inhibition of ulcer \[[@bib0285]\]. Many researchers reported different plants volatiles oil having singnificant role in anti-*Helicobacter pylori* like *Magnolia sieboldii* \[[@bib0290]\], oil-macerated garlic constituents \[[@bib0295]\] and *Aristolochia paucinervis* \[[@bib0300]\].

Adesanwo et al. \[[@bib0305]\] studied the antiulcerogenic effect of *Melaleuca bracteata* stem bark extract and showed thatthe extract significantly reduced gastric acid secretion. They also reported that the bark extract contains two important constituents' betulinic acid and oleanolic acid, play major role in anti-ulcer effect. In another attempt, Agrawal et al. \[[@bib0310]\] studied the antiulcer activity of petroleum ether, alcohol and aqueous extracts of *Smithia conferta.* Phytochemical analysis of petroleum ether extract found to have steroids, alcohol extract constitute isoflavonoids, alkaloids and carbohydrates whereas in the aqueous extract significant amount of amino acids, carbohydrates and flavonoids were present. However, the aqueous and alcoholic extracts showed significant reduction in ulcer index compared to petroleum ether extract. All through in our evolution, natural products have enormous eminence in the fields of medicine and health. Natural products along being the earth friendly, they are free from any adverse effect to the human health.

5. Future prospective {#sec0040}
=====================

Plant metabolites (natural products) have been the most successful source of potential drugs since ancient period \[[@bib0315]\]. However, due to the emergence of new human diseases with the changing environment, continuous screening and validation of secondary metabolites in the form of drug identification/designing needs to be updated. Different cheminformatics approaches like target identification, active site prediction, drug likeliness properties, biological activity and molecular docking of selected phytoligands are the key features for identifying for functional aspects of any drug.

Secondary metabolites of the plants have been recognized to elicit beneficial effects in virulent factors of diseases. The raw materials and pharmaceuticals needed for the preparation of essential drugs are largely obtained from the local herbal plants \[[@bib0320]\]. The revolution of metabolic engineering and the development molecular docking algorithms approaches lead to improved molecular simulations with crucial applications in virtual high-throughput screening and drug discovery. Analysis with molecular docking of interactions between protein-ligand, become an emerging tool in drug design \[[@bib0325]\].

In case of *Helicobacter pylori* infected individuals, the frequencies of virulent factor IFNγ cells have been increased in the antrum, which induces development of gastric ulcers \[[@bib0330]\]. Protodioscin a secondary metabolites of *Asparagus racemosus* is used as medicinal compounds against several diseases \[[@bib0335]\]. The analysis by molecular docking between the virulent factor and plant metabolites showed the interaction between structural protodioscin (PubChem CID: 441891) and interferon-γ (PDB ID: 1hig), in which all residues of interferon-γ exhibited hydrophobic interactions ([Fig.3](#fig0015){ref-type="fig"}). Although, the obtained binding energy (−26.96 kcal/mol) of protodioscin- interferon-γ complex revealed disruptions of interferon-γ integrity. These types of interactions between the virulent factors of ulcer and plants secondary metabolites open a new door in the field of designing and discovery of a new drug in the ulcer treatment.Fig. 3Interaction of Protodioscin with anti-ulcer (Interferon-y).Fig. 3
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